NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 181 filers reported holding NOVOCURE LTD in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $214,000 | -25.7% | 1,998 | -9.1% | 0.00% | – |
| Q3 2021 | $288,000 | -42.2% | 2,199 | -2.2% | 0.00% | -100.0% |
| Q2 2021 | $498,000 | +65.4% | 2,248 | -1.3% | 0.00% | – |
| Q1 2021 | $301,000 | -23.8% | 2,278 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $395,000 | +53.7% | 2,278 | -1.5% | 0.00% | – |
| Q3 2020 | $257,000 | -90.1% | 2,312 | -94.0% | 0.00% | -100.0% |
| Q1 2020 | $2,595,000 | +275.0% | 38,537 | +369.3% | 0.01% | +500.0% |
| Q4 2019 | $692,000 | +8.6% | 8,211 | -3.6% | 0.00% | 0.0% |
| Q3 2019 | $637,000 | -86.6% | 8,520 | -88.7% | 0.00% | -85.7% |
| Q2 2019 | $4,759,000 | +1236.8% | 75,263 | +918.4% | 0.01% | +600.0% |
| Q1 2019 | $356,000 | -8.5% | 7,390 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $389,000 | +88.8% | 7,430 | +12.7% | 0.00% | – |
| Q2 2018 | $206,000 | – | 6,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |